Patent 9370525 was granted and assigned to Supernus Pharmaceuticals, Inc. on June, 2016 by the United States Patent and Trademark Office.
Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.